CAS 171099-57-3: Oritavancin
Formula:C86H97Cl3N10O26
InChI:InChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1
InChI key:InChIKey=VHFGEBVPHAGQPI-LXKZPTCJSA-N
SMILES:O(C=1C2=CC3=CC1OC=4C(Cl)=CC(=CC4)[C@@H](O)[C@@H](NC([C@@H](CC(C)C)NC)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]3(C(=O)N[C@@]5(C=6C=C(C=7C([C@@H](C(O)=O)NC(=O)[C@]([C@H](O[C@H]8C[C@](C)(N)[C@@H](O)[C@H](C)O8)C=9C=C(Cl)C(O2)=CC9)(NC5=O)[H])=CC(O)=CC7O)C(O)=CC6)[H])[H])[C@H]%10[C@H](O[C@H]%11C[C@@](NCC%12=CC=C(C=C%12)C%13=CC=C(Cl)C=C%13)(C)[C@@H](O)[C@H](C)O%11)[C@@H](O)[C@H](O)[C@@H](CO)O%10
Synonyms:- (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-(4'-chloro[1,1'-biphenyl]-4-ylmethyl)vancomycin
- Ly-333328
- Orbactiv
- Oritavancin
- Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-<span class="text-smallcaps">L</span>-arabino-hexopyranosyl)-N<sup>3′′</sup>-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-
- Vancomycin, 22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-arabino-hexopyranosyl)-N3′′-[(4′-chloro[1,1′-biphenyl]-4-yl)methyl]-, (4′′R)-
Sort by
Found 4 products.
Oritavancin
CAS:Oritavancin is a semi-synthetic lipoglycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to the D-alanyl-D-alanine moiety of peptidoglycan precursors. It has been shown to be active against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens. Oritavancin also inhibits the growth of thp-1 cells in vitro and has been shown to be effective against endocarditis caused by MRSA.Formula:C86H97Cl3N10O26Purity:Min. 95%Color and Shape:PowderMolecular weight:1,793.1 g/molOritavancin(LY-333328)
CAS:Oritavancin, a semisynthetic antibiotic for skin infections, approved by FDA on August 6, 2014, targets resistant Gram-positive bacteria.Formula:C86H97Cl3N10O26Color and Shape:SolidMolecular weight:1793.12
